Background: Although fish gelatin may represent a useful alternative to bovine or porcine gelatins, the clearly recognized high prevalence of fish allergy could increase the risk of anaphylaxis to gelatin. The rationale for investigating tuna gelatin rather than gelatins from more allergenic fishes is the availability of an industrial gelatin under development. The infrequent occurrence of tuna allergy should influence the safety of a derived product. The present study investigated IgE antibodies to tuna-skin-derived gelatin in adults and children with documented fish allergy or sensitization. Methods: Serum samples were taken from 100 consecutive patients with fish allergy or sensitization and tested for IgE antibodies against hydrolyzed or nonhydrolyzed gelatin extracted from tuna skin as compared to extracts from tuna flesh, tuna skin as well as bovine or porcine gelatins. Patients with tuna allergies or sensitization were sensitive to the same tuna species (yellowfin) as that from which the gelatin was obtained. IgE antibodies to these various extracts were analyzed using SDS-PAGE and immunoblotting. Results: Only 3 of the 100 serum samples tested gave evidence of reactivity to gelatin extracted from tuna skin. Cross-reactivity between bovine/porcine and fish gelatins was not observed. Conclusion: The risk of adverse reactions to tuna skin gelatin seems to be significantly lower than the risk of fish allergy. Fish gelatin may represent a valuable alternative to bovine or porcine gelatins.

1.
Sakaguchi M, Hori H, Yoshida T, Asahi T, Aoki T, Miyatani Y, Inouye S: Development of IgE antibody to gelatin in children with systemic immediate-type reactions to vaccine. J Allergy Clin Immunol 1997;99:720–721.
2.
Sakaguchi M, Hori H, Ebihara T, Irie S, Yanagida M, Inouye S: Reactivity of the immunoglobulin E in bovine gelatin-sensitive children to gelatins from various animals. Immunology 1999;96:286–290.
3.
Ohsaki M, Tsutsumi H, Kumagai T, Yamanaka T, Wataya Y, Furukawa H, Kojima H, Saito A, Yano S, Chiba S: The relevance of Th1 and Th2 cells in immediate and nonimmediate reactions to gelatin-containing vaccine. J Allergy Clin Immunol 1999;103:276–281.
4.
Sakaguchi M, Toda M, Ebihara T, Irie S, Hori H, Imai A, Yanagida M, Miyazawa H, Ohsuna H, Ikezawa Z, Inouye S: IgE antibody to fish gelatin (type I collagen) in patients with fish allergy. J Allergy Clin Immunol 2000;106:279–284.
5.
André F, André C, Colin L, Cacaraci F, Cavagna S: Role of new allergens and of allergen consumption in the increased incidence of food sensitizations in France. Toxicology 1994;93:77–83.
6.
André F, Pène J, André C: Interleukin-4 and interferon-gamma production by peripheral blood mononuclear cells from food-allergic patients. Allergy 1996;51:350–355.
7.
André F, André C, Cavagna S: Oral food challenge increases in vitro IL-4 production by peripheral blood mononuclear cells in allergic patients. J Interferon Cytokine Res 1998;18:369–375.
8.
Bugajska-Schetter A, Elfman L, Fuchs T, Kapiotis S, Rumpold H, Valenta R, Spitzauer S: Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion. J Allergy Clin Immunol 1998;101:67–74.
9.
Ward AG, Courts A: The Science and Technology of Gelatin. New York, Academic Press, 1977.
10.
Bindslev-Jensen C, Briggs D, Osterballe M: Can we determine a threshold level for allergenic foods by statistical analysis of published data in the literature? Allergy 2002;57:741–746.
11.
Vervloet D, Senft M, Dugue P, Arnaud A, Charpin J: Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol 1983;71:535–540.
12.
Sakaguchi M, Kaneda H, Inouye S: A case of anaphylaxis to gelatin included in erythropoietin product. J Allergy Clin Immunol 1999;103:349–350.
13.
Wahl R, Kleinhans D: IgE-mediated allergic reactions to fruit gums and investigation of cross-reactivity between gelatine and modified gelatin-containing products. Clin Exp Allergy 1989;19:77–80.
14.
Sakaguchi M, Nakayama T, Inouye S: Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J Allergy Clin Immunol 1996;98:1058–1061.
15.
Sampson H, Ho D: Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol 1997;100:444–451.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.